UTI, TB, Malaria, and Antifungal Agents

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/37

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

38 Terms

1
New cards

Sulfamethoxazole/Trimethoprim (Bactrim)

(antibiotic) (Sulfonamide and Folate Synthesis Inhibitor)

MOA: Sulfonamides and trimethoprim are bacteriostatic medications that inhibit tetrahydrofolate syntheses that is needed to make DNA, RNA, & proteins.

Indications: Broad-spectrum against gram + and gram -

• Commonly used for UTI & P. Jiroveci, among others.

2
New cards

Sulfamethoxazole/Trimethoprim (Bactrim) Adverse Effects

Sulfonamide AE:

Photosensitivity & Hypersensitivity reactions, including SJS/TENS

• Hemolytic anemia

Kernicterus in newborns

Renal damage from crystalline aggregates (crystalluria)

Trimethroprim AE:

• Megaloblastic anemia

Hyperkalemia

3
New cards

Sulfamethoxazole/Trimethoprim (Bactrim) Nursing Considerations

• Monitor for rash and stop immediately if it is present.

Cross allergies w/ other sulfa-containing meds.

• Monitor CBC and CMP and progression of infection s/s.

4
New cards

Nitrofurantoin (Macrobid)

(antibiotic) (Nitrofuran)

MOA: After conversion to reactive form, causes bacterial injury due to inhibition of protein, DNA, RNA, & protein synthesis, as well as energy metabolism.

Indications: Broad-spectrum against gram + and gram -.

• Currently only used for treatment and prophylaxis in acute lower UTIs.

5
New cards

Nitrofurantoin (Macrobid) Adverse Effects

• GI effects are most common, including, N/V/D.

Pulmonary reactions, likely from hypersensitivity, leading to dyspnea, cough, and malaise.

• Various hematologic effects, including agranulocytosis, leukopenia, thrombocytopenia, and megaloblastic anemia.

6
New cards

Nitrofurantoin (Macrobid) Nursing Considerations

Not indicated for upper UTI

Encourage increased water intake and cranberry juice to avoid other potential nephrotoxic drugs. (proper hygiene)

7
New cards

Diagnosis of Tuberculosis

Step 1: Tuberculin skin test (Mantoux)

Step 2: If skin test results are positive, then chest x-ray

Step 3: If chest x-ray shows signs of TB, then culture of sputum or stomach secretions

8
New cards

Latent TB

May be Asymptomatic

9
New cards

Active TB

May present w/ productive cough >3 weeks, hemopytsis, chest pain w/ breathing/coughing, fatigue, fever, and chills.

10
New cards

TB medications typically cause problems in what organ?

Liver

11
New cards

Isoniazid (INH)

(antibiotic) (Primary Agent for Treatment and Prophylaxis of TB)

MOA: Inhibits synthesis mycolic acid, a component needed for mycobacterial cell walls.

• Bactericidal to actively dividing cell walls.

• Bacteriostatic to dormant bacteria.

12
New cards

Isoniazid (INH) Adverse Effects

Hepatotoxicity/liver injury (RUQ tenderness, changes in urine, stool, and skin)→ multilobular necrosis

Neuropathy & pyridoxine (B6) deficiency

Optic neuritis and visual disturbances.

13
New cards

Isoniazid (INH) Nursing Considerations

Do not take with antacids due to decreased absorption.

Educate on and monitor for s/s hepatitis.

Monitor liver enzymes

Educate on s/s peripheral neuropathy; may be reversible w/ vitamin B6.

Report visual changes immediately.

Risk for non-adherence due to long term treatment duration.

14
New cards

Rifampin (Rifandin)

(antibiotic) (Rifamycin) (Primary Agent of Treatment and Prophylaxis of TB)

MOA: Inhibits DNA-dependent RNA polymerase to suppress RNA synthesis and protein synthesis.

Indications:

Drug of choice (DOC) for TB in combination w/ at least one other agent due to resistance.

Leprosy (once/month dosing)

MAC (w/ ethambutol and macrolide)

15
New cards

Rifampin (Rifandin) Adverse Effects

Hepatotoxicity

Body fluid red-orange discoloration (urine, sweat, saliva, and tears)—harmless

Hematologic disorders (blood issues)

Effects r/t accelerated metabolism of oral contraceptives, warfarin, PI & NNRTI—(HIV patients at risk for TB)

16
New cards

Rifampin (Rifandin) Nursing Considerations

Educate on and monitor for s/s hepatitis

Monitor liver enzymes and CBC

Education on fluid discoloration

• Child-bearing age female patients need additional birth control

17
New cards

Pyrazinamide

(antibiotic) (First-line agent used in combo therapy for TB) (Commonly affected joints in hyperuricemia are hallux, ankle, and knee)

MOA:

• Medication is metabolized to pyrazinoic acid to lower PH.

• Inhibits m. tuberculosis enzyme, fatty acid synthetase I

Indications:

• Part of multi-drug regimen for active TB

18
New cards

Pyrazinamide Adverse Effects

Hepatotoxicity, particularly w/ concurrent TB agent use.

Hyperuricemia gouty arthritis (first digit in foot; accumulation of uric acid crystal)

19
New cards

Pyrazinamide Nursing Considerations

Educate on and monitor for s/s hepatitis

Monitor liver enzymes and serum uric acid levels

Report any gout-like s/s; use an NSAID PRN.

20
New cards

Ethambutol (Myambutol)

(antibiotic) (First-line agent used in combo therpay for TB; Also used for MAC) (E for Eyes)

MOA: Promotes a bacteriostatic action by inhibiting arabinosyl transferase resulting in impaired mycobacterial cell wall synthesis.

21
New cards

Ethambutol (Myambutol) Adverse Effects

GI tract disturbances

Optic neuritis, resulting in blurred vision, constriction of visual field, and disturbance of color discrimination.

• Possible hepatotoxicity; higher risk w/ multi-drug TB regimen.

22
New cards

Ethambutol (Myambutol) Nursing Considerations

Educate on and monitor for s/s hepatitis.

Monitor liver enzymes.

Take w/ food as needed to minimize GI upset.

Monitor for acute visual changes. (CN II—ocular)

23
New cards

Amphotericin B (Abelect)

(antibiotic) (Polyene) (Amphoterrible!)

MOA: Binds to components of fungal cell membrane to increase permeability, w/ resultant leakage leading to reduced viability.

Indications:

Broad-spectrum fungal coverage, and often DOC for most systemic mycoses.

24
New cards

Amphotericin B (Abelect) Adverse Effects

Infusion reactions (fever, chills, urticaria, nausea, and headache)—these are expected reactions and not a reason to stop the infusion!

Dysrhythmias

Nephrotoxicity

25
New cards

Amphotericin B (Abelect) Nursing Considerations

Minimizes infusion reactions w/:

• Antipyretics → fever and headache

• Antihistamines → urticaria

• Antiemetics → nausea

• Corticosteroids → fever and chills

Monitor:

• V/S closely (i.e. every 15 minutes)

• Heart rhythm on telemetry

• CMP, I/O, and kidney function

26
New cards

Itraconazole (Sporanox)

(antibiotic) (PO and IV Azole)

MOA: Inhibits synthesis of ergosterol to cause increased membrane permeability and cellular component leakage.

Indications:

• Borad-spectrum fungal coverage of mycoses of esophageal, oropharyngeal, peritoneal, urinary tract, vaginal, and systemic candida;

27
New cards

Itraconazole (Sporanox) Adverse Effects

• GI most common (N/V/D)

Cardiac suppressiondecreased ventricular ejection fraction. (HF symptoms)

Medication-associated liver injury.

28
New cards

Itraconazole (Sporanox) Nursing Considerations

Assess medication use due to many possible drug interactions. (med recocilliation!)

Administer w/ food to enhance medication absorption.

Monitor s/s of liver injury and heart failure prior to and after medication administration.

29
New cards

Nystatin

(antibiotic) (PO and Topical Polyene) (more localized)

MOA: binds to components of fungal cell membrane to increase permeability, w/ resultant leakage leading to reduced viability.

Indications: Coverage similar to amphotericin B, but limited to use due to toxicity; currently used mostly for:

Oropharyngeal candidiasis prophylaxis in patient w/ neutropenia.

• Treatment of oral and vaginal candidiasis.

30
New cards

Nystatin Adverse Effects

• GI (N/V/D) most common w/ PO.

Rash and urticaria w/ topical.

31
New cards

Nystatin Nursing Considerations

• Monitor PO route carefully w/ pediatric patients as it can be given via lozenge/troche.

• Educate patient on proper administration w/ oral suspension. (swish and spit)

32
New cards

What do malaria symptoms mirror?

The flu

33
New cards

Chloroquine (Aralen)

(Mild Malaria)

MOA: (Target the plasmodium in an effort to potentially reduce it going into the RBCs)

Prevents conversion of heme (RBCs) to nontoxic metabolites.

Concentrates heme in parasitized erythrocytes to produce lethal effect.

Indications:

DOC for mild to moderate acute attacks caused by P. vivax and P. falciparum and prophylaxis of infection in erythrocytes.

34
New cards

Chloroquine (Aralen) Adverse Effects

Rare w/ prophylactic low dose

• GI effects → discomfort and N/V

Visual disturbances

Pruritus (itching)

35
New cards

Chloroquine (Aralen) Nursing Considerations

Report condition for surveillance reporting.

Monitor patients w/ hepatic disease closely.

Minimize GI s/s by taking w/ meals.

Not able to prevent primary infection of the liver.

36
New cards

Quinidine Gluconate

(antibiotic) (Parenteral Dextro Isomer of Quinine) (Bad Malaria)

MOA:

• Causes heme (RBCs) to accumulate within parasite.

• Concentrates heme in parasitized erythrocytes to produce lethal effect.

Indications:

• DOC for severe malarial infection

37
New cards

Quinidine Gluconate Adverse Effects

• Hypotension

• Acute Circulatory Failure

• Dysrhythmias

• Cardiotoxicity

38
New cards

Quinidine Gluconate Nursing Considerations

Weight-based loading dose followed by slow IV administration over 24 hours.

Co-administered w/ tetracycline or clindamycin → monitor for associated s/s.

• Monitor heart rhythm and BP frequently; slower administration if changes noted.

Monitor electrolytes, particularly K and Mg.